Global (United States, European Union and China) High-Flow Nasal Cannula research

High-Flow Nasal Cannula Comprehensive Study by Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Carbon Monoxide Toxicity, Sleep Apnea, Acute Heart Failure, Others), Component (Air/Oxygen Blender, Nasal Cannulas, Active Humidifier, Single Heated Tube, Others), End User (Hospitals, Specialty Clinics, Long-term Care Centers, Ambulatory Care Centers, Homecare Setting) Players and Region - Global Market Outlook to 2030

High-Flow Nasal Cannula Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About High-Flow Nasal Cannula
A high-flow nasal cannula is a device, used to provide extra oxygen to a patient or person in need of respiratory help. High-flow nasal cannula contains a lightweight tube which then separates into two prongs, these separated prongs are placed in the nostrils of the patients and from which a mixture of air and oxygen flows. One end of the tube is attached to an oxygen supply such as a portable oxygen generator. This cannula is normally attached to the patient by the tube hooking around the patient's ears or by the elastic headband.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global High-Flow Nasal Cannula market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Fisher & Paykel Healthcare (New Zealand), ResMed (United States), Teijin Limited (Japan), Becton, Dickinson, and Company (United States), MEKICS CO., Ltd (South Korea), Teleflex Incorporated (United States), Smiths Medical (United States), Vapotherm (United States), Flexicare Medical (United States) and SunMed, LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Hamilton Medical (Switzerland) and Great Group Medical (Taiwan).

Segmentation Overview
AMA Research has segmented the market of Global High-Flow Nasal Cannula market by , Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, Carbon Monoxide Toxicity, Sleep Apnea, Acute Heart Failure and Others) and Region.



On the basis of geography, the market of High-Flow Nasal Cannula has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Component, the sub-segment i.e. Air/Oxygen Blender will boost the High-Flow Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the High-Flow Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increased the Number of Respiratory Disease Cases

Market Growth Drivers:
Growing Addiction for Smoking, Deteriorating Air Quality and Rising Pollution across the Globe and Increasing Geriatric Population and Growing Incidences of Asthma and COPD Across the Globe

Challenges:
Stringent Government Regulations

Restraints:
Damage Caused to the Nasal Mucosa during the Invasive Procedure

Opportunities:
Rising Prevalence of Sleep Apnea

Market Leaders and their expansionary development strategies
In February 2021, Masimo announced the U.S. introduction of softFlow®, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients. The technology, available on the softFlow 50, offers adult patients high-flow respiratory support through a soft nasal cannula by generating a consistent high flow of warm, humidified air or air/oxygen mixture.
In 2024, Intersurgical Ltd has launched the Intersurgical i-flo™ high flow nasal cannula, a new adult single use patient interface for the delivery of High Flow Oxygen Therapy (HFOT) in the hospital environment. The i-flo’s unobtrusive design has been developed with a focus on performance and patient comfort and includes a number of unique features and benefits to help ensure optimal delivery of HFOT,


Key Target Audience
High-Flow Nasal Cannula Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchiectasis
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Acute Heart Failure
  • Others
By Component
  • Air/Oxygen Blender
  • Nasal Cannulas
  • Active Humidifier
  • Single Heated Tube
  • Others

By End User
  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Homecare Setting

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Addiction for Smoking, Deteriorating Air Quality and Rising Pollution across the Globe
      • 3.2.2. Increasing Geriatric Population and Growing Incidences of Asthma and COPD Across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased the Number of Respiratory Disease Cases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global High-Flow Nasal Cannula, by Application, Component, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global High-Flow Nasal Cannula (Value)
      • 5.2.1. Global High-Flow Nasal Cannula by: Application (Value)
        • 5.2.1.1. Acute Respiratory Failure
        • 5.2.1.2. Chronic Obstructive Pulmonary Disease (COPD)
        • 5.2.1.3. Bronchiectasis
        • 5.2.1.4. Carbon Monoxide Toxicity
        • 5.2.1.5. Sleep Apnea
        • 5.2.1.6. Acute Heart Failure
        • 5.2.1.7. Others
      • 5.2.2. Global High-Flow Nasal Cannula by: Component (Value)
        • 5.2.2.1. Air/Oxygen Blender
        • 5.2.2.2. Nasal Cannulas
        • 5.2.2.3. Active Humidifier
        • 5.2.2.4. Single Heated Tube
        • 5.2.2.5. Others
      • 5.2.3. Global High-Flow Nasal Cannula by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Specialty Clinics
        • 5.2.3.3. Long-term Care Centers
        • 5.2.3.4. Ambulatory Care Centers
        • 5.2.3.5. Homecare Setting
      • 5.2.4. Global High-Flow Nasal Cannula Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global High-Flow Nasal Cannula (Volume)
      • 5.3.1. Global High-Flow Nasal Cannula by: Application (Volume)
        • 5.3.1.1. Acute Respiratory Failure
        • 5.3.1.2. Chronic Obstructive Pulmonary Disease (COPD)
        • 5.3.1.3. Bronchiectasis
        • 5.3.1.4. Carbon Monoxide Toxicity
        • 5.3.1.5. Sleep Apnea
        • 5.3.1.6. Acute Heart Failure
        • 5.3.1.7. Others
      • 5.3.2. Global High-Flow Nasal Cannula by: Component (Volume)
        • 5.3.2.1. Air/Oxygen Blender
        • 5.3.2.2. Nasal Cannulas
        • 5.3.2.3. Active Humidifier
        • 5.3.2.4. Single Heated Tube
        • 5.3.2.5. Others
      • 5.3.3. Global High-Flow Nasal Cannula by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Specialty Clinics
        • 5.3.3.3. Long-term Care Centers
        • 5.3.3.4. Ambulatory Care Centers
        • 5.3.3.5. Homecare Setting
      • 5.3.4. Global High-Flow Nasal Cannula Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global High-Flow Nasal Cannula (Price)
  • 6. High-Flow Nasal Cannula: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fisher & Paykel Healthcare (New Zealand)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ResMed (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teijin Limited (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson, and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MEKICS CO., Ltd (South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Teleflex Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Smiths Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vapotherm (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Flexicare Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SunMed, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global High-Flow Nasal Cannula Sale, by Application, Component, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global High-Flow Nasal Cannula (Value)
      • 7.2.1. Global High-Flow Nasal Cannula by: Application (Value)
        • 7.2.1.1. Acute Respiratory Failure
        • 7.2.1.2. Chronic Obstructive Pulmonary Disease (COPD)
        • 7.2.1.3. Bronchiectasis
        • 7.2.1.4. Carbon Monoxide Toxicity
        • 7.2.1.5. Sleep Apnea
        • 7.2.1.6. Acute Heart Failure
        • 7.2.1.7. Others
      • 7.2.2. Global High-Flow Nasal Cannula by: Component (Value)
        • 7.2.2.1. Air/Oxygen Blender
        • 7.2.2.2. Nasal Cannulas
        • 7.2.2.3. Active Humidifier
        • 7.2.2.4. Single Heated Tube
        • 7.2.2.5. Others
      • 7.2.3. Global High-Flow Nasal Cannula by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Specialty Clinics
        • 7.2.3.3. Long-term Care Centers
        • 7.2.3.4. Ambulatory Care Centers
        • 7.2.3.5. Homecare Setting
      • 7.2.4. Global High-Flow Nasal Cannula Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global High-Flow Nasal Cannula (Volume)
      • 7.3.1. Global High-Flow Nasal Cannula by: Application (Volume)
        • 7.3.1.1. Acute Respiratory Failure
        • 7.3.1.2. Chronic Obstructive Pulmonary Disease (COPD)
        • 7.3.1.3. Bronchiectasis
        • 7.3.1.4. Carbon Monoxide Toxicity
        • 7.3.1.5. Sleep Apnea
        • 7.3.1.6. Acute Heart Failure
        • 7.3.1.7. Others
      • 7.3.2. Global High-Flow Nasal Cannula by: Component (Volume)
        • 7.3.2.1. Air/Oxygen Blender
        • 7.3.2.2. Nasal Cannulas
        • 7.3.2.3. Active Humidifier
        • 7.3.2.4. Single Heated Tube
        • 7.3.2.5. Others
      • 7.3.3. Global High-Flow Nasal Cannula by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Specialty Clinics
        • 7.3.3.3. Long-term Care Centers
        • 7.3.3.4. Ambulatory Care Centers
        • 7.3.3.5. Homecare Setting
      • 7.3.4. Global High-Flow Nasal Cannula Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global High-Flow Nasal Cannula (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. High-Flow Nasal Cannula: by Application(USD Million)
  • Table 2. High-Flow Nasal Cannula Acute Respiratory Failure , by Region USD Million (2018-2023)
  • Table 3. High-Flow Nasal Cannula Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2018-2023)
  • Table 4. High-Flow Nasal Cannula Bronchiectasis , by Region USD Million (2018-2023)
  • Table 5. High-Flow Nasal Cannula Carbon Monoxide Toxicity , by Region USD Million (2018-2023)
  • Table 6. High-Flow Nasal Cannula Sleep Apnea , by Region USD Million (2018-2023)
  • Table 7. High-Flow Nasal Cannula Acute Heart Failure , by Region USD Million (2018-2023)
  • Table 8. High-Flow Nasal Cannula Others , by Region USD Million (2018-2023)
  • Table 9. High-Flow Nasal Cannula: by Component(USD Million)
  • Table 10. High-Flow Nasal Cannula Air/Oxygen Blender , by Region USD Million (2018-2023)
  • Table 11. High-Flow Nasal Cannula Nasal Cannulas , by Region USD Million (2018-2023)
  • Table 12. High-Flow Nasal Cannula Active Humidifier , by Region USD Million (2018-2023)
  • Table 13. High-Flow Nasal Cannula Single Heated Tube , by Region USD Million (2018-2023)
  • Table 14. High-Flow Nasal Cannula Others , by Region USD Million (2018-2023)
  • Table 15. High-Flow Nasal Cannula: by End User(USD Million)
  • Table 16. High-Flow Nasal Cannula Hospitals , by Region USD Million (2018-2023)
  • Table 17. High-Flow Nasal Cannula Specialty Clinics , by Region USD Million (2018-2023)
  • Table 18. High-Flow Nasal Cannula Long-term Care Centers , by Region USD Million (2018-2023)
  • Table 19. High-Flow Nasal Cannula Ambulatory Care Centers , by Region USD Million (2018-2023)
  • Table 20. High-Flow Nasal Cannula Homecare Setting , by Region USD Million (2018-2023)
  • Table 21. South America High-Flow Nasal Cannula, by Country USD Million (2018-2023)
  • Table 22. South America High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 23. South America High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 24. South America High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 25. Brazil High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 26. Brazil High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 27. Brazil High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 28. Argentina High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 29. Argentina High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 30. Argentina High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 31. Rest of South America High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 32. Rest of South America High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 33. Rest of South America High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 34. Asia Pacific High-Flow Nasal Cannula, by Country USD Million (2018-2023)
  • Table 35. Asia Pacific High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 37. Asia Pacific High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 38. China High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 39. China High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 40. China High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 41. Japan High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 42. Japan High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 43. Japan High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 44. India High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 45. India High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 46. India High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 47. South Korea High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 48. South Korea High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 49. South Korea High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 50. Taiwan High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 51. Taiwan High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 52. Taiwan High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 53. Australia High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 54. Australia High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 55. Australia High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 59. Europe High-Flow Nasal Cannula, by Country USD Million (2018-2023)
  • Table 60. Europe High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 61. Europe High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 62. Europe High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 63. Germany High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 64. Germany High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 65. Germany High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 66. France High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 67. France High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 68. France High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 69. Italy High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 70. Italy High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 71. Italy High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 72. United Kingdom High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 73. United Kingdom High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 74. United Kingdom High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 75. Netherlands High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 76. Netherlands High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 77. Netherlands High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 78. Rest of Europe High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 79. Rest of Europe High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 80. Rest of Europe High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 81. MEA High-Flow Nasal Cannula, by Country USD Million (2018-2023)
  • Table 82. MEA High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 83. MEA High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 84. MEA High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 85. Middle East High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 86. Middle East High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 87. Middle East High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 88. Africa High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 89. Africa High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 90. Africa High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 91. North America High-Flow Nasal Cannula, by Country USD Million (2018-2023)
  • Table 92. North America High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 93. North America High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 94. North America High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 95. United States High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 96. United States High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 97. United States High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 98. Canada High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 99. Canada High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 100. Canada High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 101. Mexico High-Flow Nasal Cannula, by Application USD Million (2018-2023)
  • Table 102. Mexico High-Flow Nasal Cannula, by Component USD Million (2018-2023)
  • Table 103. Mexico High-Flow Nasal Cannula, by End User USD Million (2018-2023)
  • Table 104. High-Flow Nasal Cannula Sales: by Application(Million Units)
  • Table 105. High-Flow Nasal Cannula Sales Acute Respiratory Failure , by Region Million Units (2018-2023)
  • Table 106. High-Flow Nasal Cannula Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region Million Units (2018-2023)
  • Table 107. High-Flow Nasal Cannula Sales Bronchiectasis , by Region Million Units (2018-2023)
  • Table 108. High-Flow Nasal Cannula Sales Carbon Monoxide Toxicity , by Region Million Units (2018-2023)
  • Table 109. High-Flow Nasal Cannula Sales Sleep Apnea , by Region Million Units (2018-2023)
  • Table 110. High-Flow Nasal Cannula Sales Acute Heart Failure , by Region Million Units (2018-2023)
  • Table 111. High-Flow Nasal Cannula Sales Others , by Region Million Units (2018-2023)
  • Table 112. High-Flow Nasal Cannula Sales: by Component(Million Units)
  • Table 113. High-Flow Nasal Cannula Sales Air/Oxygen Blender , by Region Million Units (2018-2023)
  • Table 114. High-Flow Nasal Cannula Sales Nasal Cannulas , by Region Million Units (2018-2023)
  • Table 115. High-Flow Nasal Cannula Sales Active Humidifier , by Region Million Units (2018-2023)
  • Table 116. High-Flow Nasal Cannula Sales Single Heated Tube , by Region Million Units (2018-2023)
  • Table 117. High-Flow Nasal Cannula Sales Others , by Region Million Units (2018-2023)
  • Table 118. High-Flow Nasal Cannula Sales: by End User(Million Units)
  • Table 119. High-Flow Nasal Cannula Sales Hospitals , by Region Million Units (2018-2023)
  • Table 120. High-Flow Nasal Cannula Sales Specialty Clinics , by Region Million Units (2018-2023)
  • Table 121. High-Flow Nasal Cannula Sales Long-term Care Centers , by Region Million Units (2018-2023)
  • Table 122. High-Flow Nasal Cannula Sales Ambulatory Care Centers , by Region Million Units (2018-2023)
  • Table 123. High-Flow Nasal Cannula Sales Homecare Setting , by Region Million Units (2018-2023)
  • Table 124. South America High-Flow Nasal Cannula Sales, by Country Million Units (2018-2023)
  • Table 125. South America High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 126. South America High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 127. South America High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 128. Brazil High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 129. Brazil High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 130. Brazil High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 131. Argentina High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 132. Argentina High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 133. Argentina High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 134. Rest of South America High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 135. Rest of South America High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 136. Rest of South America High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 137. Asia Pacific High-Flow Nasal Cannula Sales, by Country Million Units (2018-2023)
  • Table 138. Asia Pacific High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 139. Asia Pacific High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 140. Asia Pacific High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 141. China High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 142. China High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 143. China High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 144. Japan High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 145. Japan High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 146. Japan High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 147. India High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 148. India High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 149. India High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 150. South Korea High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 151. South Korea High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 152. South Korea High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 153. Taiwan High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 154. Taiwan High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 155. Taiwan High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 156. Australia High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 157. Australia High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 158. Australia High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 159. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 160. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 161. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 162. Europe High-Flow Nasal Cannula Sales, by Country Million Units (2018-2023)
  • Table 163. Europe High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 164. Europe High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 165. Europe High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 166. Germany High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 167. Germany High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 168. Germany High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 169. France High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 170. France High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 171. France High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 172. Italy High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 173. Italy High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 174. Italy High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 175. United Kingdom High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 176. United Kingdom High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 177. United Kingdom High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 178. Netherlands High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 179. Netherlands High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 180. Netherlands High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 181. Rest of Europe High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 182. Rest of Europe High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 183. Rest of Europe High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 184. MEA High-Flow Nasal Cannula Sales, by Country Million Units (2018-2023)
  • Table 185. MEA High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 186. MEA High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 187. MEA High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 188. Middle East High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 189. Middle East High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 190. Middle East High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 191. Africa High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 192. Africa High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 193. Africa High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 194. North America High-Flow Nasal Cannula Sales, by Country Million Units (2018-2023)
  • Table 195. North America High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 196. North America High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 197. North America High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 198. United States High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 199. United States High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 200. United States High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 201. Canada High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 202. Canada High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 203. Canada High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 204. Mexico High-Flow Nasal Cannula Sales, by Application Million Units (2018-2023)
  • Table 205. Mexico High-Flow Nasal Cannula Sales, by Component Million Units (2018-2023)
  • Table 206. Mexico High-Flow Nasal Cannula Sales, by End User Million Units (2018-2023)
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. High-Flow Nasal Cannula: by Application(USD Million)
  • Table 218. High-Flow Nasal Cannula Acute Respiratory Failure , by Region USD Million (2025-2030)
  • Table 219. High-Flow Nasal Cannula Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2025-2030)
  • Table 220. High-Flow Nasal Cannula Bronchiectasis , by Region USD Million (2025-2030)
  • Table 221. High-Flow Nasal Cannula Carbon Monoxide Toxicity , by Region USD Million (2025-2030)
  • Table 222. High-Flow Nasal Cannula Sleep Apnea , by Region USD Million (2025-2030)
  • Table 223. High-Flow Nasal Cannula Acute Heart Failure , by Region USD Million (2025-2030)
  • Table 224. High-Flow Nasal Cannula Others , by Region USD Million (2025-2030)
  • Table 225. High-Flow Nasal Cannula: by Component(USD Million)
  • Table 226. High-Flow Nasal Cannula Air/Oxygen Blender , by Region USD Million (2025-2030)
  • Table 227. High-Flow Nasal Cannula Nasal Cannulas , by Region USD Million (2025-2030)
  • Table 228. High-Flow Nasal Cannula Active Humidifier , by Region USD Million (2025-2030)
  • Table 229. High-Flow Nasal Cannula Single Heated Tube , by Region USD Million (2025-2030)
  • Table 230. High-Flow Nasal Cannula Others , by Region USD Million (2025-2030)
  • Table 231. High-Flow Nasal Cannula: by End User(USD Million)
  • Table 232. High-Flow Nasal Cannula Hospitals , by Region USD Million (2025-2030)
  • Table 233. High-Flow Nasal Cannula Specialty Clinics , by Region USD Million (2025-2030)
  • Table 234. High-Flow Nasal Cannula Long-term Care Centers , by Region USD Million (2025-2030)
  • Table 235. High-Flow Nasal Cannula Ambulatory Care Centers , by Region USD Million (2025-2030)
  • Table 236. High-Flow Nasal Cannula Homecare Setting , by Region USD Million (2025-2030)
  • Table 237. South America High-Flow Nasal Cannula, by Country USD Million (2025-2030)
  • Table 238. South America High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 239. South America High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 240. South America High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 241. Brazil High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 242. Brazil High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 243. Brazil High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 244. Argentina High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 245. Argentina High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 246. Argentina High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 247. Rest of South America High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 248. Rest of South America High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 249. Rest of South America High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 250. Asia Pacific High-Flow Nasal Cannula, by Country USD Million (2025-2030)
  • Table 251. Asia Pacific High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 252. Asia Pacific High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 253. Asia Pacific High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 254. China High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 255. China High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 256. China High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 257. Japan High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 258. Japan High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 259. Japan High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 260. India High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 261. India High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 262. India High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 263. South Korea High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 264. South Korea High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 265. South Korea High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 266. Taiwan High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 267. Taiwan High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 268. Taiwan High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 269. Australia High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 270. Australia High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 271. Australia High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 272. Rest of Asia-Pacific High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 273. Rest of Asia-Pacific High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 274. Rest of Asia-Pacific High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 275. Europe High-Flow Nasal Cannula, by Country USD Million (2025-2030)
  • Table 276. Europe High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 277. Europe High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 278. Europe High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 279. Germany High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 280. Germany High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 281. Germany High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 282. France High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 283. France High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 284. France High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 285. Italy High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 286. Italy High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 287. Italy High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 288. United Kingdom High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 289. United Kingdom High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 290. United Kingdom High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 291. Netherlands High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 292. Netherlands High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 293. Netherlands High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 294. Rest of Europe High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 295. Rest of Europe High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 296. Rest of Europe High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 297. MEA High-Flow Nasal Cannula, by Country USD Million (2025-2030)
  • Table 298. MEA High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 299. MEA High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 300. MEA High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 301. Middle East High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 302. Middle East High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 303. Middle East High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 304. Africa High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 305. Africa High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 306. Africa High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 307. North America High-Flow Nasal Cannula, by Country USD Million (2025-2030)
  • Table 308. North America High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 309. North America High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 310. North America High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 311. United States High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 312. United States High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 313. United States High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 314. Canada High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 315. Canada High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 316. Canada High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 317. Mexico High-Flow Nasal Cannula, by Application USD Million (2025-2030)
  • Table 318. Mexico High-Flow Nasal Cannula, by Component USD Million (2025-2030)
  • Table 319. Mexico High-Flow Nasal Cannula, by End User USD Million (2025-2030)
  • Table 320. High-Flow Nasal Cannula Sales: by Application(Million Units)
  • Table 321. High-Flow Nasal Cannula Sales Acute Respiratory Failure , by Region Million Units (2025-2030)
  • Table 322. High-Flow Nasal Cannula Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region Million Units (2025-2030)
  • Table 323. High-Flow Nasal Cannula Sales Bronchiectasis , by Region Million Units (2025-2030)
  • Table 324. High-Flow Nasal Cannula Sales Carbon Monoxide Toxicity , by Region Million Units (2025-2030)
  • Table 325. High-Flow Nasal Cannula Sales Sleep Apnea , by Region Million Units (2025-2030)
  • Table 326. High-Flow Nasal Cannula Sales Acute Heart Failure , by Region Million Units (2025-2030)
  • Table 327. High-Flow Nasal Cannula Sales Others , by Region Million Units (2025-2030)
  • Table 328. High-Flow Nasal Cannula Sales: by Component(Million Units)
  • Table 329. High-Flow Nasal Cannula Sales Air/Oxygen Blender , by Region Million Units (2025-2030)
  • Table 330. High-Flow Nasal Cannula Sales Nasal Cannulas , by Region Million Units (2025-2030)
  • Table 331. High-Flow Nasal Cannula Sales Active Humidifier , by Region Million Units (2025-2030)
  • Table 332. High-Flow Nasal Cannula Sales Single Heated Tube , by Region Million Units (2025-2030)
  • Table 333. High-Flow Nasal Cannula Sales Others , by Region Million Units (2025-2030)
  • Table 334. High-Flow Nasal Cannula Sales: by End User(Million Units)
  • Table 335. High-Flow Nasal Cannula Sales Hospitals , by Region Million Units (2025-2030)
  • Table 336. High-Flow Nasal Cannula Sales Specialty Clinics , by Region Million Units (2025-2030)
  • Table 337. High-Flow Nasal Cannula Sales Long-term Care Centers , by Region Million Units (2025-2030)
  • Table 338. High-Flow Nasal Cannula Sales Ambulatory Care Centers , by Region Million Units (2025-2030)
  • Table 339. High-Flow Nasal Cannula Sales Homecare Setting , by Region Million Units (2025-2030)
  • Table 340. South America High-Flow Nasal Cannula Sales, by Country Million Units (2025-2030)
  • Table 341. South America High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 342. South America High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 343. South America High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 344. Brazil High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 345. Brazil High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 346. Brazil High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 347. Argentina High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 348. Argentina High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 349. Argentina High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 350. Rest of South America High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 351. Rest of South America High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 352. Rest of South America High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 353. Asia Pacific High-Flow Nasal Cannula Sales, by Country Million Units (2025-2030)
  • Table 354. Asia Pacific High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 355. Asia Pacific High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 356. Asia Pacific High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 357. China High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 358. China High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 359. China High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 360. Japan High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 361. Japan High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 362. Japan High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 363. India High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 364. India High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 365. India High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 366. South Korea High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 367. South Korea High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 368. South Korea High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 369. Taiwan High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 370. Taiwan High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 371. Taiwan High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 372. Australia High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 373. Australia High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 374. Australia High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 375. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 376. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 377. Rest of Asia-Pacific High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 378. Europe High-Flow Nasal Cannula Sales, by Country Million Units (2025-2030)
  • Table 379. Europe High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 380. Europe High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 381. Europe High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 382. Germany High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 383. Germany High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 384. Germany High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 385. France High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 386. France High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 387. France High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 388. Italy High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 389. Italy High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 390. Italy High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 391. United Kingdom High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 392. United Kingdom High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 393. United Kingdom High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 394. Netherlands High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 395. Netherlands High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 396. Netherlands High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 397. Rest of Europe High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 398. Rest of Europe High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 399. Rest of Europe High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 400. MEA High-Flow Nasal Cannula Sales, by Country Million Units (2025-2030)
  • Table 401. MEA High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 402. MEA High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 403. MEA High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 404. Middle East High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 405. Middle East High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 406. Middle East High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 407. Africa High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 408. Africa High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 409. Africa High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 410. North America High-Flow Nasal Cannula Sales, by Country Million Units (2025-2030)
  • Table 411. North America High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 412. North America High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 413. North America High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 414. United States High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 415. United States High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 416. United States High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 417. Canada High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 418. Canada High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 419. Canada High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 420. Mexico High-Flow Nasal Cannula Sales, by Application Million Units (2025-2030)
  • Table 421. Mexico High-Flow Nasal Cannula Sales, by Component Million Units (2025-2030)
  • Table 422. Mexico High-Flow Nasal Cannula Sales, by End User Million Units (2025-2030)
  • Table 423. Research Programs/Design for This Report
  • Table 424. Key Data Information from Secondary Sources
  • Table 425. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global High-Flow Nasal Cannula: by Application USD Million (2018-2023)
  • Figure 5. Global High-Flow Nasal Cannula: by Component USD Million (2018-2023)
  • Figure 6. Global High-Flow Nasal Cannula: by End User USD Million (2018-2023)
  • Figure 7. South America High-Flow Nasal Cannula Share (%), by Country
  • Figure 8. Asia Pacific High-Flow Nasal Cannula Share (%), by Country
  • Figure 9. Europe High-Flow Nasal Cannula Share (%), by Country
  • Figure 10. MEA High-Flow Nasal Cannula Share (%), by Country
  • Figure 11. North America High-Flow Nasal Cannula Share (%), by Country
  • Figure 12. Global High-Flow Nasal Cannula: by Application Million Units (2018-2023)
  • Figure 13. Global High-Flow Nasal Cannula: by Component Million Units (2018-2023)
  • Figure 14. Global High-Flow Nasal Cannula: by End User Million Units (2018-2023)
  • Figure 15. South America High-Flow Nasal Cannula Share (%), by Country
  • Figure 16. Asia Pacific High-Flow Nasal Cannula Share (%), by Country
  • Figure 17. Europe High-Flow Nasal Cannula Share (%), by Country
  • Figure 18. MEA High-Flow Nasal Cannula Share (%), by Country
  • Figure 19. North America High-Flow Nasal Cannula Share (%), by Country
  • Figure 20. Global High-Flow Nasal Cannula share by Players 2023 (%)
  • Figure 21. Global High-Flow Nasal Cannula share by Players (Top 3) 2023(%)
  • Figure 22. Global High-Flow Nasal Cannula share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Fisher & Paykel Healthcare (New Zealand) Revenue, Net Income and Gross profit
  • Figure 25. Fisher & Paykel Healthcare (New Zealand) Revenue: by Geography 2023
  • Figure 26. ResMed (United States) Revenue, Net Income and Gross profit
  • Figure 27. ResMed (United States) Revenue: by Geography 2023
  • Figure 28. Teijin Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Teijin Limited (Japan) Revenue: by Geography 2023
  • Figure 30. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 32. MEKICS CO., Ltd (South Korea) Revenue, Net Income and Gross profit
  • Figure 33. MEKICS CO., Ltd (South Korea) Revenue: by Geography 2023
  • Figure 34. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 35. Teleflex Incorporated (United States) Revenue: by Geography 2023
  • Figure 36. Smiths Medical (United States) Revenue, Net Income and Gross profit
  • Figure 37. Smiths Medical (United States) Revenue: by Geography 2023
  • Figure 38. Vapotherm (United States) Revenue, Net Income and Gross profit
  • Figure 39. Vapotherm (United States) Revenue: by Geography 2023
  • Figure 40. Flexicare Medical (United States) Revenue, Net Income and Gross profit
  • Figure 41. Flexicare Medical (United States) Revenue: by Geography 2023
  • Figure 42. SunMed, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 43. SunMed, LLC (United States) Revenue: by Geography 2023
  • Figure 44. Global High-Flow Nasal Cannula: by Application USD Million (2025-2030)
  • Figure 45. Global High-Flow Nasal Cannula: by Component USD Million (2025-2030)
  • Figure 46. Global High-Flow Nasal Cannula: by End User USD Million (2025-2030)
  • Figure 47. South America High-Flow Nasal Cannula Share (%), by Country
  • Figure 48. Asia Pacific High-Flow Nasal Cannula Share (%), by Country
  • Figure 49. Europe High-Flow Nasal Cannula Share (%), by Country
  • Figure 50. MEA High-Flow Nasal Cannula Share (%), by Country
  • Figure 51. North America High-Flow Nasal Cannula Share (%), by Country
  • Figure 52. Global High-Flow Nasal Cannula: by Application Million Units (2025-2030)
  • Figure 53. Global High-Flow Nasal Cannula: by Component Million Units (2025-2030)
  • Figure 54. Global High-Flow Nasal Cannula: by End User Million Units (2025-2030)
  • Figure 55. South America High-Flow Nasal Cannula Share (%), by Country
  • Figure 56. Asia Pacific High-Flow Nasal Cannula Share (%), by Country
  • Figure 57. Europe High-Flow Nasal Cannula Share (%), by Country
  • Figure 58. MEA High-Flow Nasal Cannula Share (%), by Country
  • Figure 59. North America High-Flow Nasal Cannula Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Fisher & Paykel Healthcare (New Zealand)
  • ResMed (United States)
  • Teijin Limited (Japan)
  • Becton, Dickinson, and Company (United States)
  • MEKICS CO., Ltd (South Korea)
  • Teleflex Incorporated (United States)
  • Smiths Medical (United States)
  • Vapotherm (United States)
  • Flexicare Medical (United States)
  • SunMed, LLC (United States)
Additional players considered in the study are as follows:
Hamilton Medical (Switzerland) , Great Group Medical (Taiwan)
Select User Access Type

Key Highlights of Report


Mar 2024 216 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) High-Flow Nasal Cannula research Quantitative research analysis
Global (United States, European Union and China) High-Flow Nasal Cannula research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Fisher & Paykel Healthcare (New Zealand), ResMed (United States), Teijin Limited (Japan), Becton, Dickinson, and Company (United States), MEKICS CO., Ltd (South Korea), Teleflex Incorporated (United States), Smiths Medical (United States), Vapotherm (United States), Flexicare Medical (United States) and SunMed, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased the Number of Respiratory Disease Cases" is seen as one of major influencing trends for High-Flow Nasal Cannula Market during projected period 2023-2030.
The High-Flow Nasal Cannula market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global (United States, European Union and China) High-Flow Nasal Cannula research Report?

Have a Query? Click Here

Other Related Reports

Chemotherapy Devices Comprehensive Study by Type (LVP (Large Volume Pump), Syringe Pump, Elastomeric Pumps), Application (Hospital & Clinic, Home Care), Cancer Type (Blood Cancer, Breast Cancer, Pros...
$ 3450
Nicotine Patch Comprehensive Study by Type (16-hour patches, 24-hour patches), Application (Male, Female), Age Limit (Age Below 30, Age 30-50, Age above 50), Sales Channel (Supermarkets, Pharmacy sto...
$ 3450
Virtual 3D Nanorobots Comprehensive Study by Type (Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots), Application (Dentistry, Emerging Drug Delivery, Brain Aneurysm, Cancer detec...
$ 3650
Dental 3D Printing Devices Comprehensive Study by Type (Printers, Software, Components), Application (Orthopedic Implants, Dental Restoratives), Technique (Digital Light Projection, 3D Jet Printing, ...
$ 3750
Medical Aesthetic Devices Comprehensive Study by Type (Energy-based Aesthetic Device(Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device), Non-energy...
$ 3750
Hearing Amplifiers Comprehensive Study by Type (Behind-the-ear (BTE), Receiver-In-Ear (Ric), Completely-In-Canal, Around The Neck), Application (Hearing Impaired Patients, The Elderly, Others), Funct...
$ 3650